Srihari S Naidu MD FACC FAHA FSCAI
Adult Congenital Heart Disease, Heart Failure & Transplantation, Interventional Cardiology
Director, Cardiac Catheterization Laboratory Director, Hypertrophic Cardiomyopathy Center Westchester Medical Center Professor of Medicine, New York Medical College
Join to View Full Profile
120 Mineola BlvdSte 500Mineola, NY 11501
Phone+1 516-663-4480
Fax+1 516-663-9535
Dr. Naidu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Interventional Cardiology, 2003 - 2004- University of Pennsylvania Health SystemFellowship, Cardiovascular Disease, 2000 - 2003
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1997 - 2000
The Warren Alpert Medical School of Brown UniversityClass of 1997
Certifications & Licensure
NY State Medical License 1998 - 2025
MI State Medical License 2014 - 2021
PA State Medical License 2000 - 2008
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FSCAI) Society for Cardiovascular Angiography and Interventions
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- Long-term Effects of Mavacamten on Patients Based on Hypertrophic Cardiomyopathy Pathogenic Genetic Variant Status: Insights from VALOR-HCM Trial.Milind Y Desai, Anjali Owens, Sara Saberi, Andrew Wang, Kathy Wolski
Circulation. Genomic and Precision Medicine. 2025-03-31 - Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex: Insights From the VALOR-HCM Trial.Milind Y Desai, Sara Saberi, Jeffrey B Geske, Andrew Wang, Paul Cremer
JACC. Heart Failure. 2025-03-03 - 6 citationsMavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM: Insights From the VALOR-HCM Trial.Milind Y Desai, Yuichiro Okushi, Kathy Wolski, Jeffrey B Geske, Anjali Owens
JACC. Cardiovascular Imaging. 2025-03-01
Lectures
- Interventional Heart Failure2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- EtOH Ablation Step by Step2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Needle Knives and Screws: Challenges and Conundrums in HCM2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- Join now to see all
Authored Content
- SCAI Expert Consensus Update on Best Practices in the Cardiac Catheterization Laboratory: Optimizing Quality of CareJuly 2021
- ISCHEMIA Trial: Is Revascularization Worth the Risk?November 2019
- ISCHEMIA Trial: Is Revascularization Worth the Risk?November 2019
- Energy and Momentum in the Diagnosis and Management of Cardiogenic ShockApril 2018
- Join now to see all
Press Mentions
Bleeding After MCS in DanGer Shock: When, Where, and What to Do?October 31st, 2024- New Children's Book Teaches Families About Hypertrophic CardiomyopathySeptember 11th, 2024
- Mount Sinai Queens Cardiology Chief, George D. Dangas, MD, MSCAI, Named New SCAI PresidentMay 23rd, 2023
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
